PT Kimia Farma Tbk

KAEF

ID1000070303

Drug Retailers

End-of-day quote INDONESIA S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
735 ^IDR	-1.34%		+0.68%	-49.13%

2023	PT Kimia Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	PT Kimia Farma Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	CI

PT Akar Investasi Indonesia, CIZJ Limited signed a sale and purchase deed to acquire unknown majority stake in PT Kimia Farma Apotek for IDR 460 billion.

December 29, 2022

PT Akar Investasi Indonesia, CIZJ Limited signed a sale and purchase deed to acquire unknown majority stake in PT Kimia Farma Apotek for IDR 460 billion on December 27, 2022. Tumbuan & Partners acted as legal advisor to PT Kimia Farma Apotek. Cellia Cognard, Stephanie, Santi Darmawan, Monica Sun of Herbert Smith Freehills LLP acted as legal advisor to The Silk Road Fund Co Ltd.

Latest news about PT Kimia Farma Tbk

PT Kimia Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
PT Kimia Farma Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-31	CI
PT Kimia Farma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-01	CI
PT Kimia Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-01	CI
Indonesia investment authority, China Silk Road Fund subscribe to Kimia Farma's convertible bonds	23-02-23	RE
PT Akar Investasi Indonesia, CIZJ Limited signed a sale and purchase deed to acquire unknown majority stake in PT Kimia Farma Apotek for IDR 460 billion.	22-12-29	CI
China's Silk Road Fund to become investor in Indonesia's state pharma firms	22-11-13	RE
PT Kimia Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-31	CI
PT Kimia Farma Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-29	CI
PT Kimia Farma Tbk(IDX:KAEF) dropped from S&P Global BMI Index	22-09-19	CI
PT Kimia Farma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
PT Kimia Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck's Covid-19 Pill	22-01-20	DJ
PT Kimia Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021	21-12-07	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-30	CI
PT Kimia Farma Persero Tbk : Indonesia gives tax break to makers of personal protective equipment	20-06-19	RE
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-26	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Nine Months Ended September 30, 2019	19-11-01	CI
PT Kimia Farma Tbk(IDX:KAEF) added to S&P Global BMI Index	19-09-23	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Half Year Ended June 30, 2019	19-09-02	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-03	CI
Pt Kimia Farma Persero Tbk Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-28	CI
PT Kimia Farma Tbk completed the acquisition of 56.77% stake in PT Phapros, Tbk from PT Rajawali Nusantara Indonesia for an enterprise value of IDR 1.4 trillion.	19-03-26	CI

Chart PT Kimia Farma Tbk

Duration

Period

More charts

Company Profile

PT Kimia Farma Tbk is an Indonesia-based company, which is engaged in producing, distributing, and marketing chemical industry product, active pharmaceutical ingredients (API) and high function chemicals (HFC). Its segments include Manufacturing, Distribution, Retail, and Other. The Manufacturing segment includes chemical and pharmaceutical manufacturing, research and development, and manufacturing marketing and marketing of quinine and essential oils; manufacturing and marketing of active pharmaceutical ingredients and HFC, and manufacturing and marketing of pharmaceutical products. The distribution segment is engaged in distribution of pharmaceutical products to domestic market and to the international market, including Saudi Arabia, the United States, Netherlands, the United Kingdom, China, Malaysia, and several other countries. The Retail segment is engaged in the sale of medicines and pharmaceutical products directly to customers.

Sector

Drug Retailers

Calendar

2024-04-30 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
PT KIMIA FARMA TBK	-49.13%	252M
WALGREENS BOOTS ALLIANCE, INC.	-32.21%	15.27B
JD HEALTH INTERNATIONAL INC.	-31.97%	10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-30.42%	6.06B
YIFENG PHARMACY CHAIN CO., LTD.	+8.14%	6.04B
MATSUKIYOCOCOKARA & CO.	-11.41%	5.86B
NAHDI MEDICAL COMPANY	-0.88%	4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+52.19%	4.29B
CLICKS GROUP LIMITED	-12.31%	3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-14.86%	3.33B